Answers are grounded in this paper and cite their sources.
Background Musculoskeletal disorders are a leading cause of non-fatal disability worldwide. This study aimed to estimate the burden of musculoskeletal disorders at national and subnational levels in Italy from 1990 to 2023. Methods Global Burden of Disease Study 2023 estimates of prevalence and years lived with disability (YLDs) were analyzed for low back pain, neck pain, osteoarthritis, rheumatoid arthritis, gout, and other musculoskeletal disorders, by sex, age, and location across 19 regions and two autonomous provinces. All-age and age-standardized rates per 100,000 population and 95% uncertainty intervals (UIs) were reported. Findings In 2023, musculoskeletal disorders affected 20.0 million (95% UI 19.0–21.0) people in Italy, compared with 15.1 million (14.3–16.1) in 1990. All-age prevalence rates increased by 27.5% (25.1–29.9), from 26,666.4 to 34,001.4 per 100,000, whereas age-standardized rates increased by 2.5% (1.4–3.5), from 20,483.9 to 20,987.0. All-age YLD rates increased by 24.2% (20.4–28.5), from 2571.8 to 3193.8 per 100,000, whereas age-standardized rates increased by 2.5% (0.6–4.1), from 2016.3 to 2067.2. Low back pain was the leading contributor to disability (age-standardized YLD rate 1055.2 [743.8–1431.1] per 100,000 in 2023). Osteoarthritis all-age YLD rates increased by 52.6% (50.5–55.0), from 369.0 to 563.2 per 100,000, whereas age-standardized rates increased by 4.9% (3.8–6.0), from 242.3 to 254.2. Burden was generally higher in females than males. All-age rates were numerically higher in northern than in southern macro-areas, but differences were small and largely disappeared after age standardization. Interpretation The increasing burden of musculoskeletal disorders in Italy, alongside modest changes in age-standardized rates, suggests an important contribution from population aging. Persistent differences by sex and location, partly attenuated after age standardization, highlight the importance of accounting for demographic and regional variation when developing targeted public health strategies.
No takes yet. Share an insight, caveat, or question.
Pedersini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: